Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antitumor compounds from tunicates.

K L Rinehart1

  • 1Department of Chemistry, University of Illinois, 454 Roger Adams Laboratory, 600 So. Mathews Avenue, Urbana, Illinois 61801, USA.

Medicinal Research Reviews
|December 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of an egyptian mummy resin by mass spectrometry.

Journal of the American Society for Mass Spectrometry·2013
Same author

Erratum - " Didemnins and Tunichlorin: Novel Natural Products from the Marine Tunicate Trididemnum solidum.

Journal of natural products·2011
Same author

Human fatalities from cyanobacteria: chemical and biological evidence for cyanotoxins.

Environmental health perspectives·2001
Same author

Enantiospecific synthesis of N-Boc-Adda: a linear approach.

Organic letters·2000
Same author

Isolation and characterization of microcystins from a river nile strain of Oscillatoria tenuis Agardh ex Gomont.

Toxicon : official journal of the International Society on Toxinology·2000
Same author

Electrospray ionization mass spectrometric analysis of microcystins, cyclic heptapeptide hepatotoxins: modulation of charge states and [M + H]+ to [M + Na]+ ratio.

Journal of the American Society for Mass Spectrometry·1999
Same journal

Decoding the Toxicity of Synthetic Cannabinoids: From Receptor Activation to Multiorgan Dysfunction.

Medicinal research reviews·2026
Same journal

AI-Driven Synthesis in Medicinal Chemistry: Integrating Large Language Models, Robotic Automation, and Sustainability Metrics to Accelerate Drug Discovery.

Medicinal research reviews·2026
Same journal

Advances in Structural Diversity, Pharmacological Activities, and Drug Development of β-Carboline Alkaloids.

Medicinal research reviews·2026
Same journal

Small-Molecule Kinase Inhibitors Modulating Circadian Rhythms.

Medicinal research reviews·2026
Same journal

Phosphonates as Modulators of Brain Chemistry.

Medicinal research reviews·2026
Same journal

A Comprehensive Insight of Mechanisms of Drugs Targeting Ion Channels: Exemplified by Marine Natural Products and Their Analogues.

Medicinal research reviews·2026
See all related articles

Marine-derived tunicates yield potent antitumor compounds. Didemnin B showed promise but caused cardiotoxicity; its analogue, Aplidine, is in clinical trials. Ecteinascidins are also under investigation.

Area of Science:

  • Marine pharmacology
  • Natural product chemistry
  • Antitumor drug development

Background:

  • Tunicates are a rich source of marine-derived compounds with antitumor potential.
  • Didemnin B (DB) and Ecteinascidins (ETs) are two families of tunicate-derived compounds that have advanced to clinical trials.
  • DB showed efficacy in non-Hodgkins lymphoma but was discontinued due to cardiotoxicity.

Purpose of the Study:

  • To review marine-derived antitumor agents from tunicates.
  • To highlight the development of Didemnin B, Aplidine, and Ecteinascidin 743.
  • To discuss the potential of these compounds in cancer therapy.

Main Methods:

  • Review of clinical trial data and spectroscopic studies.
  • Isolation and structural elucidation of marine natural products.

Related Experiment Videos

  • Synthesis and chemical modification of bioactive compounds.

    • Main Results:

    • Didemnin B (DB) demonstrated efficacy but exhibited cardiotoxicity.
    • Aplidine (dehydrodidemnin B), a related compound, shows improved activity and reduced toxicity, entering Phase I trials.
    • Ecteinascidin 743 (ET 743) is undergoing Phase II clinical trials, with potential for aquaculture or synthetic production.

    Conclusions:

    • Tunicate-derived compounds like Aplidine and Ecteinascidin 743 represent promising avenues for cancer treatment.
    • Overcoming toxicity and ensuring supply through synthesis or aquaculture are key for future development.
    • Marine natural products continue to be a vital resource for novel anticancer drug discovery.